文献
J-GLOBAL ID:201702231436665219
整理番号:17A1119082
B前駆細胞型急性リンパ芽球性白血病における新規JAK2F694L変異を標的による高用量療法へのルクソリチニブの統合【Powered by NICT】
Integration of ruxolitinib into dose-intensified therapy targeted against a novel JAK2 F694L mutation in B-precursor acute lymphoblastic leukemia
著者 (9件):
Mayfield Jodi R.
(Department of Pediatrics, Hematology Oncology, University of New Mexico, New Mexico, Albuquerque)
,
Czuchlewski David R.
(Department of Pathology, University of New Mexico, New Mexico, Albuquerque)
,
Gale James M.
(Department of Pathology, TriCore Reference Laboratories, Albuquerque, New Mexico)
,
Matlawska-Wasowska Ksenia
(Department of Pediatrics, Hematology Oncology, University of New Mexico, New Mexico, Albuquerque)
,
Vasef Mohammad A.
(Department of Pathology, University of New Mexico, New Mexico, Albuquerque)
,
Nickl Christian
(Department of Pediatrics, Hematology Oncology, University of New Mexico, New Mexico, Albuquerque)
,
Pickett Gavin
(Analytical and Translational Genomics Shared Resource, UNM Comprehensive Cancer Center, University of New Mexico, New Mexico, Albuquerque)
,
Ness Scott A.
(Department of Internal Medicine, Division of Molecular Medicine and UNM Comprehensive Cancer Center, University of New Mexico, New Mexico, Albuquerque)
,
Winter Stuart S.
(Department of Pediatrics, Hematology Oncology, University of New Mexico, New Mexico, Albuquerque)
資料名:
Pediatric Blood & Cancer
(Pediatric Blood & Cancer)
巻:
64
号:
5
ページ:
null
発行年:
2017年
JST資料番号:
W2716A
ISSN:
1545-5009
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)